Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Reply to Why patients shouldn't “own” their medical records

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout


  1. New Hampshire Information and Analysis Center. Residential Care and Health Facility Licensing Patients' Bill of Rights. New Hampshire Codes Title XI Hospitals and Sanitaria Ch. 151 (1 January 2014), accessed 14 March 2016.

  2. Kish, L.J. & Topol, E.J. Unpatients—why patients should own their medical data. Nat. Biotechnol. 33, 921–924 (2015).

    Article  CAS  Google Scholar 

  3. Standen, A. Patients crusade for access to their medical device data. Shots: Health News from NPR (28 May 2012), accessed 14 March 2016.

    Google Scholar 

  4. Office of President Barak Obama at The White House. Precision Medicine Initiative: Privacy and Trust Principles. The White House (9 November 2015), accessed 14 March 2016.

  5. Davis, J.H. President weighs in on data from genes. New York Times (25 February 2016), accessed 14 March 2016.

Download references

Ethics declarations

Competing interests

The author declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reply to Why patients shouldn't “own” their medical records. Nat Biotechnol 34, 586–587 (2016).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research